Results 81 to 90 of about 86,753 (203)

Emerg Infect Dis [PDF]

Mycobacterium genavense infection, a rare nontuberculous mycobacteria infection, occurs in heavily immunocompromised patients (i.e., those with advanced HIV disease, genetic disorders, or acquired immunologic disorders and those undergoing ...

core  

IgG4-related disease simulating Hodgkin lymphoma in a child

, 2016
Immunoglobulin (Ig) G4-related disease is a recently described syndrome characterized by mass forming lymphoplasmacytic tissue infiltration and elevated serum IgG4 concentrations usually affecting middle-aged or older individuals.
D. Eric Ewing, MD, Richard D. Hammer, MD, Ewing, D. Eric, Hammer, Richard D.   +3 more
core   +1 more source

Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma [PDF]

, 2018
A retrospective study was performed of 341 cases of extralymphatic Hodgkin lymphoma (HL) to identify its characteristics and outcomes. Sites were lung in 29 patients (44%), bone in 22 (33%), and liver in 5 (18%).
Cimmino, Antonia, Tommasina Perrone, Pezzolla, Angela, Antonia Cimmino, Francesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, Laddaga, Filomena Emanuela, D'Abbicco, Dario, Perrone, Tommasina, Asabella, Artor Niccoli, Giorgina Specchia, SINDACO, PAOLA, Rubini, Giuseppe, Gaudio, Francesco, Angela Pezzolla, Paola Sindaco, Giuseppe Rubini, Specchia, Giorgina, Filomena Emanuela Laddaga, Pedote, Pasquale, Dario D'Abbicco   +21 more
core   +1 more source

Hodgkin's Disease [PDF]

Journal of Clinical Pathology, 1987
openaire   +4 more sources

Hodgkins disease [PDF]

British Journal of Cancer, 2001
C, Ferme, J M, Cosset, B, Fervers, C, Sebban, B, Cutuli, M, Henry-Amar, J, Stines, F, Giammarile, P, Bey, A M, Carella, T, Philip   +10 more
openaire   +2 more sources

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy

Pharmaceuticals, 2015
There has been a recent emergence of novel targeted agents for treatment of Hodgkin and non-Hodgkin lymphoma. In particular, antibodies and antibody-drug conjugates directed against surface antigens, agents that block immune checkpoint pathways, and ...
Natalie S. Grover, Steven I. Park
doaj   +1 more source

Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report

BMC Ophthalmology
Background Ocular manifestations are known for non-Hodgkin lymphoma, but are rare for Hodgkin lymphoma. We report a case of Vogt-Koyanagi-Harada (VKH) disease presenting as serous retinal detachment and uveitis in both eyes in a child undergoing ...
Mutsumi Koyama, Euido Nishijima, Takaya Honda, Chizuru Gonmori-Ohta, Takeaki Sasamoto, Katsuyuki Tanaka, Akira Watanabe, Tadashi Nakano, Masaharu Akiyama   +8 more
doaj   +1 more source

PROFILES registry: Quality of life Hodgkin lymphoma May 2010

, 2016
The PROFILES registry offers scientific data in the area of medical psychology and more specific on quality of life of cancer survivors. The PROFILES registry is open to academics anywhere in the world for scientific purposes, free of charge. The archive
Oerlemans, S. (Tilburg University), Poll - Franse, Prof. Dr. L. van de (Tilburg University) DAI=info:eu-repo/dai/nl/327781785   +1 more
core   +1 more source

Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease. [PDF]

BMC Res Notes, 2020
Tiemann M, Samoilova V, Atiakshin D, Buchwalow I.   +3 more
europepmc   +1 more source

NCCN practice guidelines for Hodgkin\u27s disease

, 1999
The National Comprehensive Cancer Network (NCCN) Practice Guidelines for Hodgkin\u27s Disease provide a comprehensive framework for the diagnosis, treatment, and management of patients with Hodgkin\u27s lymphoma. These guidelines, developed by a panel of
Gordon, Leo, Abrams, Richard, Bloomfield, Clara, Kaminski, Mark, Bierman, Paul, Cox, James, Hoppe, Richard, Bernstein, Steven, Horning, Sandra   +8 more
core